Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
3 3 Search
2025
Comparison of glucose fluctuation between metformin combined with acarbose or sitagliptin in Chinese patients with type 2 diabetes: A multicenter, randomized, active-controlled, open-label, parallel design clinical trial
Chinese Medical Journal
2025
NLRP3 inflammasomes pathway: a key target for Metformin
Inflammopharmacology
2020
Acarbose/metformin/repaglinide
Reactions Weekly